These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12691700)
1. Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection. Sreenarasimhaiah J; Jaramillo A; Crippin J; Lisker-Melman M; Chapman WC; Mohanakumar T Hum Immunol; 2003 May; 64(5):497-504. PubMed ID: 12691700 [TBL] [Abstract][Full Text] [Related]
2. Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T-cell responses. Pillai V; Lee WM; Thiele DL; Karandikar NJ J Viral Hepat; 2007 May; 14(5):318-29. PubMed ID: 17439521 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463 [TBL] [Abstract][Full Text] [Related]
4. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579 [TBL] [Abstract][Full Text] [Related]
5. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy? Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862 [TBL] [Abstract][Full Text] [Related]
6. Differences in hepatitis C virus (HCV)-specific CD8 T-cell phenotype during pegylated alpha interferon and ribavirin treatment are related to response to antiviral therapy in patients chronically infected with HCV. Caetano J; Martinho A; Paiva A; Pais B; Valente C; Luxo C J Virol; 2008 Aug; 82(15):7567-77. PubMed ID: 18480446 [TBL] [Abstract][Full Text] [Related]
7. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Kamal SM; Fehr J; Roesler B; Peters T; Rasenack JW Gastroenterology; 2002 Oct; 123(4):1070-83. PubMed ID: 12360469 [TBL] [Abstract][Full Text] [Related]
9. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G; Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489 [TBL] [Abstract][Full Text] [Related]
10. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
11. Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients. Capa L; Soriano V; García-Samaniego J; Nuñez M; Romero M; de Mendoza C; Cascajero A; Muñoz F; González-Lahoz J; Benito JM Antivir Ther; 2007; 12(4):459-68. PubMed ID: 17668554 [TBL] [Abstract][Full Text] [Related]
12. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin. Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132 [TBL] [Abstract][Full Text] [Related]
13. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C. Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800 [TBL] [Abstract][Full Text] [Related]
14. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. Martin B; Hennecke N; Lohmann V; Kayser A; Neumann-Haefelin C; Kukolj G; Böcher WO; Thimme R J Hepatol; 2014 Sep; 61(3):538-43. PubMed ID: 24905492 [TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of pegylated interferon in patients co-infected with HIV and HCV who failed standard interferon therapy]. Ke YC; Li LH; Hu FY; He Y; Lan Y; Chen XJ; Tang XP; Cai WP Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):181-5. PubMed ID: 27095760 [TBL] [Abstract][Full Text] [Related]
16. HCV genotype-3a T cell immunity: specificity, function and impact of therapy. Humphreys IS; von Delft A; Brown A; Hibbert L; Collier JD; Foster GR; Rahman M; Christian A; Klenerman P; Barnes E Gut; 2012 Nov; 61(11):1589-99. PubMed ID: 22337948 [TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearance. Aberle JH; Perstinger G; Weseslindtner L; Sinzinger U; Gurguta C; Steindl-Munda P; Kundi M; Popow-Kraupp T; Ferenci P; Holzmann H J Infect Dis; 2007 May; 195(9):1315-9. PubMed ID: 17397001 [TBL] [Abstract][Full Text] [Related]
18. T-cell homeostasis in chronic HCV-infected patients treated with interferon and ribavirin or an interferon-free regimen. Hartling HJ; Birch C; Gaardbo JC; Hove M; Trøseid M; Clausen MR; Gerstoft J; Ullum H; Nielsen SD APMIS; 2015 Oct; 123(10):903-11. PubMed ID: 26279289 [TBL] [Abstract][Full Text] [Related]
19. Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin. Milazzo L; Foschi A; Mazzali C; Viola A; Ridolfo A; Galli M; Antinori S AIDS Res Hum Retroviruses; 2012 Sep; 28(9):989-93. PubMed ID: 22220723 [TBL] [Abstract][Full Text] [Related]
20. HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution. Larrubia JR; Lokhande MU; Moreno-Cubero E; García-Garzón S; Miquel J; Parra-Cid T; González-Praetorious A; Perna C; Lázaro A; Sanz-de-Villalobos E Cell Immunol; 2013; 286(1-2):31-8. PubMed ID: 24287274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]